Log In
Print
BCIQ
Print
Print this Print this
 

Trastuzumab-PBD conjugates

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionTrastuzumab antibody-drug conjugates (ADCs) containing cytotoxic pyrrolobenzodiazepine (PBD) dimer drug linkers
Molecular Target Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today